Iovance Biotherapeutics, Inc.

NASDAQ:IOVA

11.44 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008
Assets:
Current Assets:
Cash & Cash Equivalents 114.888231.73178.22967.32913.96982.152145.373166.47103.744.90919.672-0.0050.511.2970.0080.003
Short Term Investments 164.979240.114426.181562.108293.112386.371059.75390.058000.0050.009000
Cash and Short Term Investments 279.867471.845595.998629.437307.081468.523145.373166.47103.744.90919.6720.0050.521.2970.0080.003
Net Receivables 0.151000000000000000
Inventory 10.372000000000000000
Other Current Assets 17.4587.2713.5466.6639.4126.8513.9173.0420.2770.0660.1740.0070.0040.00300
Total Current Assets 307.848471.845507.956636.1312.531475.374149.29169.512103.97744.97519.8460.0070.5241.3010.0080.003
Non-Current Assets:
Property, Plant & Equipment, Net 176.545178.247169.921113.91519.2312.6832.452.3741.6761.5320.0280.0220.0280.1600.003
Goodwill 0000000000000000
Intangible Assets 229.2580000000000000.160.0010
Goodwill and Intangible Assets 229.2580000000000000.160.0010
Long Term Investments 66.436.4391.5885.5255.4500000000000
Tax Assets 0000000000000000
Other Non-Current Assets 0.27-178.2477.86812.9187.4432.7643.6330000-0.0220.016-0.1600
Total Non-Current Assets 472.5036.43269.377132.35832.1245.4476.0832.3741.6761.5320.0280.0220.0440.160.0010.003
Total Assets 780.351663.982777.333768.458344.655480.821155.373171.886105.65346.50719.8740.0290.5681.4610.010.006
Liabilities & Equity:
Current Liabilities:
Account Payables 33.12326.60327.37713.51315.5672.7391.2320.8630.9581.2480.4131.0980.190.0300
Short Term Debt 7.77712.5875.0576.2847.2520000006.4815000
Tax Payables 0000000000000000
Deferred Revenue 0000000000000.222000
Other Current Liabilities 69.40652.29556.76635.07416.26511.6598.664.1050.6720.4131.8573.7697.9380.7930.0230.003
Total Current Liabilities 110.30691.48589.254.87139.08414.3989.8924.9681.631.6622.2711.34913.3490.8230.0230.003
Non-Current Liabilities:
Long Term Debt 184.44666.47445.3754.24800000000000
Deferred Revenue Non-Current 66.085000000000000000
Deferred Tax Liabilities Non-Current 17.347000000000000000
Other Non-Current Liabilities 10011.7142.3520.230.297000000000
Total Non-Current Liabilities 85.43284.44666.47457.0896.60.230.297000000000
Total Liabilities 195.738164.344155.674111.9645.68414.6289.8924.9681.631.6622.2711.34913.3490.8230.0230.003
Equity:
Preferred Stock 0.0030.0030.0030.0040.0040.0060.0070.00800000000
Common Stock 0.0110.0080.0070.0060.0050.0050.0030.0030.0020.0010.0010.0030.0030.0030.0050.005
Retained Earnings -2,012.375-1,568.338-1,172.445-830.193-570.612-372.76-249.18-157.116-104.222-76.562-64.527-30.684-27.377-1.682-0.074-0.059
Accumulated Other Comprehensive Income/Loss 2.526-0.902-0.6010.0190.22-0.04200.0290.048-0.104-0.016-0.009-0.003000
Other Total Stockholders Equity 2,594.4482,068.8671,794.6951,486.662869.354838.984394.651323.994208.195121.5182.14619.3714.5952.3170.0560.056
Total Shareholders Equity 584.613499.638621.659656.498298.971466.193145.481166.918104.02344.84517.604-11.319-12.7810.638-0.0130.002
Total Equity 584.613499.638621.659656.498298.971466.193145.481166.918104.02344.84517.604-11.319-12.7810.638-0.0130.002
Total Liabilities & Shareholders Equity 780.351663.982777.333768.458344.655480.821155.373171.886105.65346.50719.8740.0290.5681.4610.010.006